Skip to main content
. 2020 Jan 6;20:6. doi: 10.1186/s12935-019-1081-x

Fig. 3.

Fig. 3

miR-490-3p was down-regulated in HCC patients and inversely modulated by BCYRN1. a The binding site between BCYRN1 and miR-490-3p was exhibited. b The luciferase activity was detected in WT-BCYRN1 and MUT-BCYRN1, **P < 0.01. c Low expression of miR-490-3p was presented in HCC patients, P < 0.0001. d HCC patients with lower expression of miR-490-3p easily resulted in unfavorable prognosis